ERG and vascular neoplasm: For instance, one recent study demonstrated strong endothelial immunoreactivity for ERG in both benign and malignant vascular tumors, as well as other vascular lesions, including arteriovenous malformations (AVMs) and papillary endothelial hyperplasia [12].